Litigation Details for Millennium Pharmaceuticals, Inc. v. MSN Laboratories Private Ltd. (D. Del. 2016)

Millennium Pharmaceuticals, Inc. v. MSN Laboratories Private Ltd. (D. Del. 2016)

Docket		Date Filed	2016-12-18
Court	District Court, D. Delaware	Date Terminated	2018-01-18
Cause	35:271 Patent Infringement	Assigned To	Gregory Moneta Sleet
Jury Demand	Defendant	Referred To
Patents	6,713,446; 6,958,319
Link to Docket	External link to docket

Details for Millennium Pharmaceuticals, Inc. v. MSN Laboratories Private Ltd. (D. Del. 2016)

Date Filed	Document No.	Description	Snippet	Link To Document
2017-02-13	17		- that claims 20, 31, 49, and 53 of U.S. Patent No. 6,713,446 are invalid due to obviousness; that all…other than claims 20, 31, 49, and 53 of U.S. Patent No. 6,713,446 are dismissed with prejudice; and that the…2016 19 January 2018 1:16-cv-01255 830 Patent Defendant District Court, D. Delaware	External link to document
2018-01-10	25	Exhibit A	infringe, claims 20, 31, 49, and 53 of U.S. Patent No. 6,713,446 (the “Asserted Claims”); …the date of expiration of the ’446 patent, including any applicable exclusivities and … Products prior to the expiration of the ’446 patent; and 5. the parties shall bear their…2016 19 January 2018 1:16-cv-01255 830 Patent Defendant District Court, D. Delaware	External link to document
2018-01-18	26		U.S. Patent Nos. 6,713,446 (the '"446 patent) and 6,958,319 (the '"319 patent"…to the expiration ofU.S. Patent Nos. 6,713,446 ("the '446 patent") and 6,958,319 ("…quot;the '319 patent"), which have been listed in connection with VELCADE® for Injection in…of claims 20, 31, 49, and 53 of the '446 patent (the "Asserted Claims") (D.I. 15, 16)…claims and counterclaims relating to the '319 patent have been dismissed with prejudice (D.I. 15,	External link to document